Safety Concerns Halt High-dose Tenecteplase Stroke Study ...Middle East

Medscape - News
The NOR-TEST 2A trial was stopped after increased rates of ICH and mortality were seen in the group assigned to tenecteplase 0.4 mg/kg compared with the standard dose of alteplase. Medscape Medical News

Hence then, the article about safety concerns halt high dose tenecteplase stroke study was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Safety Concerns Halt High-dose Tenecteplase Stroke Study )

Apple Storegoogle play

Last updated :

Also on site :



Latest News